Maria Mora Pinzon, MD, MS, FACPM, has been named a 2023 faculty scholar with the NIA IMPACT Collaboratory. Dr. Mora Pinzon has been appointed to the Stakeholder Engagement Team (SET) for a one-year term through June 30, 2024. The Collaboratory is working to build pragmatic clinical trials for dementia by embedding accessible clinical trials in …
Maria Mora Pinzon, MD, MS discussed a study from Stanford University that showed a potential link between people who received a shingles vaccine and a reduced risk of developing dementia
On June 8, 2023, Wisconsin Governor Tony Evers and First Lady Kathy Evers welcomed people living with dementia and their caregivers, to dementia friendly events at the Governor’s Executive Residence.
Summer 2023 issue describes work of Dr. Chin and highlights Dr. Carlsson and Dr. Johnson
Photos from the 2023 Breaking the Silence community event.
The work of the Wisconsin Alzheimer’s Institute Regional Milwaukee Office is featured in a segment on television station WTMJ-TV Milwaukee. Gina Green-Harris, MBA, director of WAI Regional Milwaukee Office, is interviewed in the segment. Green-Harris describes how the office opened in 2008 with a goal of increasing awareness, education about Alzheimer’s disease and particularly its impact on communities of color.
Gina Green-Harris is chairperson of the Governor’s Health Equity Council
Maria Mora Pinzon, MD, MS, FACPM, recently appeared on Telemundo Wisconsin in a news segment discussing FDA approval of the drug lecanemab. The drug gained approval through an accelerated approval process in January 2023. Dr. Mora Pinzon is assistant professor at University of Wisconsin School of Medicine and Public Health and a scientist with the …
On behalf of the Initiative to End Alzheimer’s, we are pleased to announce the IEA Innovation Fund, providing project support for researchers at Wisconsin Alzheimer’s Institute and Wisconsin Alzheimer’s Disease Research Center. The fund was launched in March 2023, with initial support of $100,000 to be awarded on a rolling basis. The IEA Innovation Fund …
UW Alzheimer’s disease researchers Dr. Carlsson, Dr. Johnson and Dr. Chin discuss Alzheimer’s drug lecanemab in video episode of Dementia Matters podcast.